
Testblu Diagnostics provides an AI-powered blood test to detect cancer in dogs early. It uses a non-invasive liquid biopsy that analyzes cfDNA with next-generation sequencing and AI models. The service is a SaaS diagnostics offering for veterinarians and dog owners, with a multi-cancer focus. The MVP shows accuracy over 90% for four cancer types in real-world veterinary settings. The company targets a large canine cancer screening market through a vet-first network and scalable deployment.

Testblu Diagnostics provides an AI-powered blood test to detect cancer in dogs early. It uses a non-invasive liquid biopsy that analyzes cfDNA with next-generation sequencing and AI models. The service is a SaaS diagnostics offering for veterinarians and dog owners, with a multi-cancer focus. The MVP shows accuracy over 90% for four cancer types in real-world veterinary settings. The company targets a large canine cancer screening market through a vet-first network and scalable deployment.